Qube Research & Technologies (QRT)
CAMP icon

Qube Research & Technologies (QRT)’s CAMP4 Therapeutics CAMP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$109K Buy
+24,803
New +$118K ﹤0.01% 3057
2025
Q3 		– Sell
-14,871
Closed -$21.6K – 3595
2025
Q2 		$21.6K Buy
+14,871
New +$29.6K ﹤0.01% 3251

Other funds holding CAMP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Qube Research & Technologies (QRT)'s CAMP Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in CAMP4 Therapeutics (CAMP) in Q1 2026: 24,803 shares worth $109K. The stake represents ﹤0.01% of the portfolio and ranks #3057 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in CAMP as recently as Q2 2025.

Qube Research & Technologies (QRT) first reported a position in CAMP in Q2 2025 and has held it in 2 quarters since. 46 funds tracked by Wall St. Rank hold CAMP as of Q1 2026.

  • Qube Research & Technologies (QRT) held 24,803 shares of CAMP4 Therapeutics worth $109K as of Q1 2026.
  • CAMP4 Therapeutics was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • CAMP4 Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3057 holding.
  • Qube Research & Technologies (QRT) first reported a position in CAMP4 Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • 46 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.